Nα-Fmoc-Nγ-Azido-D-2,4-diaminobutyric acid
Need Assistance?
  • US & Canada:
    +
  • UK: +

Nα-Fmoc-Nγ-Azido-D-2,4-diaminobutyric acid

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Nα-Fmoc-Nγ-Azido-D-2,4-diaminobutyric acid is a click chemistry reagent containing an azide.

Category
Azido Amino Acids
Catalog number
BAT-007734
CAS number
1263047-53-5
Molecular Formula
C19H18N4O4
Molecular Weight
366.40
Nα-Fmoc-Nγ-Azido-D-2,4-diaminobutyric acid
IUPAC Name
(2R)-4-azido-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid
Synonyms
(2R)-4-azido-2-(Fmoc-amino)butanoic acid; Fmoc-D-Dab(N3)-OH; Fmoc-D-azidohomoalanine; Fmoc-d-aha-oh; (R)-4-Azido-2-(Fmoc-amino)-butanoic acid; (2R)-4-azido-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid; Fmoc D ALA OH
Appearance
White crystalline powder
Purity
≥ 98% (HPLC)
Melting Point
122-128 °C
Storage
Store at 2-8 °C
InChI
InChI=1S/C19H18N4O4/c20-23-21-10-9-17(18(24)25)22-19(26)27-11-16-14-7-3-1-5-12(14)13-6-2-4-8-15(13)16/h1-8,16-17H,9-11H2,(H,22,26)(H,24,25)/t17-/m1/s1
InChI Key
CLEZARXVEABQBI-QGZVFWFLSA-N
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CCN=[N+]=[N-])C(=O)O
1. Molecular and Mechanistic Characterization of PddB, the First PLP-Independent 2,4-Diaminobutyric Acid Racemase Discovered in an Actinobacterial D-Amino Acid Homopolymer Biosynthesis
Kazuya Yamanaka, Ryo Ozaki, Yoshimitsu Hamano, Tadao Oikawa Front Microbiol. 2021 Jun 10;12:686023. doi: 10.3389/fmicb.2021.686023. eCollection 2021.
We recently disclosed that the biosynthesis of antiviral γ-poly-D-2,4-diaminobutyric acid (poly-D-Dab) in Streptoalloteichus hindustanus involves an unprecedented cofactor independent stereoinversion of Dab catalyzed by PddB, which shows weak homology to diaminopimelate epimerase (DapF). Enzymological properties and mechanistic details of this enzyme, however, had remained to be elucidated. Here, through a series of biochemical characterizations, structural modeling, and site-directed mutageneses, we fully illustrate the first Dab-specific PLP-independent racemase PddB and further provide an insight into its evolution. The activity of the recombinant PddB was shown to be optimal around pH 8.5, and its other fundamental properties resembled those of typical PLP-independent racemases/epimerases. The enzyme catalyzed Dab specific stereoinversion with a calculated equilibrium constant of nearly unity, demonstrating that the reaction catalyzed by PddB is indeed racemization. Its activity was inhibited upon incubation with sulfhydryl reagents, and the site-directed substitution of two putative catalytic Cys residues led to the abolishment of the activity. These observations provided critical evidence that PddB employs the thiolate-thiol pair to catalyze interconversion of Dab isomers. Despite the low levels of sequence similarity, a phylogenetic analysis of PddB indicated its particular relevance to DapF among PLP-independent racemases/epimerases. Secondary structure prediction and 3D structural modeling of PddB revealed its remarkable conformational analogy to DapF, which in turn allowed us to predict amino acid residues potentially responsible for the discrimination of structural difference between diaminopimelate and its specific substrate, Dab. Further, PddB homologs which seemed to be narrowly distributed only in actinobacterial kingdom were constantly encoded adjacent to the putative poly-D-Dab synthetase gene. These observations strongly suggested that PddB could have evolved from the primary metabolic DapF in order to organize the biosynthesis pathway for the particular secondary metabolite, poly-D-Dab. The present study is on the first molecular characterization of PLP-independent Dab racemase and provides insights that could contribute to further discovery of unprecedented PLP-independent racemases.
2. The 'neurotoxicity' of L-2,4-diaminobutyric acid
R M O'Neal, C H Chen, C S Reynolds, S K Meghal, R E Koeppe Biochem J. 1968 Feb;106(3):699-706. doi: 10.1042/bj1060699.
The neurolathyrogen l-2,4-diaminobutyric acid is concentrated by liver, and liver damage can yield neurotoxicity; thus the neurotoxicity caused by this compound may be due to liver damage followed by secondary brain damage. 1. The intraperitoneal administration of toxic doses of l-2,4-diaminobutyric acid to rats resulted in hyperirritability, tremors and convulsions in 12-20hr. and increased the concentration of ammonia of blood and brain slightly and the concentration of glutamine of brain two- to three-fold. By contrast, toxic doses of l-homoarginine, l-lysine, l-leucine and ammonium acetate caused dyspnoea, extreme prostration, and in some cases coma in 15-30min., and increased the concentration of ammonia of blood significantly and the concentration of glutamine of brain slightly. These results indicate that l-2,4-diaminobutyric acid caused a chronic ammonia toxicity, whereas the other amino acids and ammonium acetate resulted in an acute ammonia toxicity. 2. Liver slices from l-2,4-diaminobutyric acid-treated animals and normal liver slices preincubated with l-2,4-diaminobutyric acid utilized ammonia and formed urea at a lower rate than control slices from normal rats. 3. l-2,4-Diaminobutyric acid inhibited competitively ornithine carbamoyltransferase of rat liver homogenates, thus demonstrating that this reaction is a primary site of toxicity for this neurolathyrogen. Although we were unable to show marked elevations of blood ammonia concentration after treatment with l-2,4-diaminobutyric acid, these results are interpreted to mean that ammonia utilization (urea synthesis) in liver is inhibited by l-2,4-diaminobutyric acid and that at least part of the neurotoxicity is due to a prolonged slight increase in body ammonia concentration.
Online Inquiry
Verification code
Inquiry Basket